标杆管理
外包
小贩
普通合伙企业
过程管理
业务
知识管理
计算机科学
数据科学
营销
财务
作者
Andrew J. Dolman,Xiaojing Yu,Gusev Ai
出处
期刊:Bioanalysis
[Future Science Ltd]
日期:2020-08-01
卷期号:12 (16): 1117-1127
被引量:1
标识
DOI:10.4155/bio-2020-0164
摘要
Outsourcing is a common strategy across the pharmaceutical industry and clinical research. CROs offer many choices for selecting outsourcing partners for bioanalytical and biomarker support. We aimed this paper to provide critical insights into CRO benchmarking and selection using a bioanalytical challenge approach performing fit-for-purpose ligand-binding assay. Bioanalytical challenge (method validation and sample analysis) offer Pharma sponsors a great opportunity to stress test CRO technical and scientific competency, quality systems and operational capabilities. In addition, CROs demonstrated their real-life performance in communication, time management and cost - key contributors to a successful sponsor-CRO partnership. Benchmarking CROs based on objective assay data and real-life experiences will help sponsors to make better-informed decisions in vendor selection.
科研通智能强力驱动
Strongly Powered by AbleSci AI